Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Flex Pharma, Inc.

TRADE

NASDAQ: FLKSHealthcare / Biotechnology / USA
0.44-0.01-2.22%Vol 297 7721Y Perf -87.07%
Sep 18th, 2018 15:59
BID0.44 ASK0.45
Open0.47 Previous Close0.45
Pre-Market0.44 After-Trading-
 -0.01 -2.22%  - -%
Target Price
1.00 
Analyst Rating
Hold 3.00
Potencial %
127.27 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)8 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
0.35 
Earnings Date
5th Nov 2018

Today's Price Range

0.410.47

 

52wk Range

0.418.98

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-11.76%
3 Months
-64.84%
6 Months
-94.08%
1 Year
-87.07%
3 Years
-96.89%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
FLKS0.44-0.0100-2.22
AAPL218.240.36000.17
GOOG1 161.225.17000.45
MSFT113.211.07000.95
XOM83.630.22000.26
WFC54.500.19000.35
JNJ140.540.58000.41
FB160.30-0.2800-0.17
GE12.66-0.0400-0.31
JPM114.300.46000.40
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.20
Current Ratio 4.50
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin51.30
EBIT Margin-3 113.70
EBITDA Margin-3 088.90
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 0.63
PS Ratios 7.59
Price to Cash Flow -
Price to Free Cash Flow -0.30
Cash Flow Per Share -1.77
Price to Tangible Book0.63
Book Value per Share0.74
Enterprise Value (in ths.)-7 346
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -117.56
Return on Assets (5Y Avg) -
ROA last 12 Months -101.92
Return on Capital (5Y Avg) -
ROC last 12 Months -119.61
Return on invested Capital Q -51.29
Return on invested Capital Y-77.88
Assets Turnover0.00
Receivables Turnover70.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)1 108
Revenue per Share 0.06
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.39-0.50-28.21
Q01 2018-0.50-0.468.00
Q04 2017-0.56-0.4617.86
Q03 2017-0.62-0.5412.90
Q02 2017-0.63-0.5119.05
Q01 2017-0.63-0.4922.22
Q04 2016-0.84-0.4842.86
Q03 2016-0.70-0.657.14
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.4515.09Positive
9/2018 QR-0.4616.36Positive
12/2018 FY-1.709.57Positive
12/2019 FY-1.548.88Positive
Next Report Date5th Nov 2018
Estimated EPS Next Report-0.25
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume297 772
Shares Outstanding (in ths.)18 070
Trades Count551
Dollar Volume118 270
Avg. Volume244 470
Avg. Weekly Volume299 309
Avg. Monthly Volume285 157
Avg. Quarterly Volume301 223

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

64%36%

Bearish Bullish

36%64%

Bearish Bullish

58%42%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
2 (40.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (100.00 %)
2 (100.00 %)
3 (60.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Moderate Buy
2.20

There are no comments yet.

News

x